Serum Thrombospondin-1 Levels by Glycemic Status in Type 2 Diabetes — a Pilot Study

Background: Thrombospondin-1 (TSP-1) is a matricellular glycoprotein involved in angiogenesis, vascular homeostasis, and metabolic signaling. Elevated circulating TSP-1 levels have been associated with diabetes and glycemic parameters, but evidence regarding differences according to glycemic-control status remains limited. This study aimed to compare serum TSP-1 levels between controlled and uncontrolled type 2 diabetes (T2D) and to explore their associations with glycemic and clinical variables. Methods: A cross-sectional study was conducted among 85 adults with T2D recruited from Hasanuddin University Hospital and Dr. Wahidin Sudirohusodo General Hospital, Makassar, Indonesia. Glycemic control was classified as controlled (HbA1c < 7%) or uncontrolled (HbA1c ≥7%). Serum TSP-1 levels were measured using enzyme-linked immunosorbent assay (ELISA). Group differences were analyzed using the Mann–Whitney U test, while associations between TSP-1 and clinical variables were examined using Spearman’s rank correlation. Results: Of the 85 participants, 16 (18.8%) had controlled glycemic status and 69 (81.2%) had uncontrolled glycemic status. Median serum TSP-1 levels were 42.72 ng/mL (IQR 35.29) in the controlled group and 43.95 ng/mL (IQR 35.38) in the uncontrolled group, with no significant difference between groups (U = 438.0, p = 0.200). Serum TSP-1 levels showed weak positive correlations with HbA1c (ρ = 0.216, p = 0.047) and fasting plasma glucose (ρ = 0.265, p = 0.015), and a weak negative correlation with age (ρ = −0.267, p = 0.014). No significant correlations were found with body mass index, lipid profile, platelet count, or blood pressure. Conclusions: Serum TSP-1 levels did not differ significantly according to HbA1c-defined glycemic-control status in patients with T2D. However, weak positive associations with HbA1c and fasting plasma glucose suggest a potential relationship between TSP-1 and glycemic regulation. Larger studies with balanced group sizes and multivariable analyses are warranted to clarify the clinical significance of TSP-1 in T2D.

Authors

Institutions

Publication Details

Journal
Clinical Diabetology
Published
2026-11-16
DOI
https://doi.org/10.5603/cd.115165
Primary Topic
Adipokines, Inflammation, and Metabolic Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Serum Thrombospondin-1 Levels by Glycemic Status in Type 2 Diabetes — a Pilot Study

Liong Boy Kurniawan, Nurahmi Nurahmi, Himawan Dharmayani, Andi Alfian Zainuddin et al.
2 links
Clinical Diabetology
Adipokines, Inflammation, and Metabolic Diseases
article

Serum Thrombospondin-1 Levels by Glycemic Status in Type 2 Diabetes — a Pilot Study

Liong Boy Kurniawan, Nurahmi Nurahmi, Himawan Dharmayani, Andi Alfian Zainuddin, Dwi Suci Irianti
article en

Abstract

Background: Thrombospondin-1 (TSP-1) is a matricellular glycoprotein involved in angiogenesis, vascular homeostasis, and metabolic signaling. Elevated circulating TSP-1 levels have been associated with diabetes and glycemic parameters, but evidence regarding differences according to glycemic-control status remains limited. This study aimed to compare serum TSP-1 levels between controlled and uncontrolled type 2 diabetes (T2D) and to explore their associations with glycemic and clinical variables. Methods: A cross-sectional study was conducted among 85 adults with T2D recruited from Hasanuddin University Hospital and Dr. Wahidin Sudirohusodo General Hospital, Makassar, Indonesia. Glycemic control was classified as controlled (HbA1c < 7%) or uncontrolled (HbA1c ≥7%). Serum TSP-1 levels were measured using enzyme-linked immunosorbent assay (ELISA). Group differences were analyzed using the Mann–Whitney U test, while associations between TSP-1 and clinical variables were examined using Spearman’s rank correlation. Results: Of the 85 participants, 16 (18.8%) had controlled glycemic status and 69 (81.2%) had uncontrolled glycemic status. Median serum TSP-1 levels were 42.72 ng/mL (IQR 35.29) in the controlled group and 43.95 ng/mL (IQR 35.38) in the uncontrolled group, with no significant difference between groups (U = 438.0, p = 0.200). Serum TSP-1 levels showed weak positive correlations with HbA1c (ρ = 0.216, p = 0.047) and fasting plasma glucose (ρ = 0.265, p = 0.015), and a weak negative correlation with age (ρ = −0.267, p = 0.014). No significant correlations were found with body mass index, lipid profile, platelet count, or blood pressure. Conclusions: Serum TSP-1 levels did not differ significantly according to HbA1c-defined glycemic-control status in patients with T2D. However, weak positive associations with HbA1c and fasting plasma glucose suggest a potential relationship between TSP-1 and glycemic regulation. Larger studies with balanced group sizes and multivariable analyses are warranted to clarify the clinical significance of TSP-1 in T2D.

Clinical Diabetology
Hasanuddin University (ID)
Good health and well-being
Adipokines, Inflammation, and Metabolic Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon